Aripiprazole generichealth

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Aripiprazole 15 mg
Available from:
CARSL Consulting
INN (International Name):
Aripiprazole 15 mg
Dosage:
15 mg
Pharmaceutical form:
Tablet
Composition:
Active: Aripiprazole 15 mg Excipient: Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose
Prescription type:
Prescription
Manufactured by:
Ind-Swift Laboratories Limited
Therapeutic indications:
Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. Aripiprazole monotherapy is indicated for acute and maintenance treatment of manic and mixed episodes with Bipolar I Disorder with or without psychotic features. Aripiprazole is indicated as an adjunctive therapy to either lithium or valporate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features.
Product summary:
Package - Contents - Shelf Life: Blister pack, Al/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C
Authorization number:
TT50-9292b
Authorization date:
2013-05-10

Similar products

Search alerts related to this product

Share this information